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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A274the presence or absence of 0.5uM simvastatin. Real-time polymerase
chain reaction (PCR) was used to quantify gene expression of BMP-2,
BMP-7, SOX-9, COL1A2, and COL2A1.
Results: A gross representation of the reparative tissue bridging the
cylindrical defects was shown in 4 out of 6 specimen of simvastatin
group 4 weeks after surgery. Conversely, in control group, such bridging
tissuewas observed in 2 of 6 specimens. At 8weeks, full thickness defect
remained in 1 specimen in the simvastatin group while 3 in the control
group. At 12 weeks, reparative tissues bridging the defects were shown
in all specimens in the simvastatin group but in the control group, full-
thickness defects remained in 2 of 6 specimens. According to the
quantitative analysis, the volume of the regenerated tissue in the sim-
vastatin group was greater than that in the control group at all end
points, reaching signiﬁcance at 8 and 12 weeks. Further, the quality
scores for the regenerative tissuewere superior in the simvastatin group
at all end points. Immunohistochemical assays demonstrated a strongly
positive staining for type-I collagen, type-II collagen, BMP-2 and BMP-7
in the reparative tissue at 12-week time point in the simvastatin group.
In vitroThe real-time PCR analysis showed that simvastatin signiﬁcantly
up-regulated BMP-2, BMP-7, and COL2A1 gene expression at 4 hours
time-point.
Conclusions: The present study demonstrated that simvastatin stimu-
lated reparative responses in the rabbit meniscal defect model.
Immunohistochemical assay indicated that the reparative tissue was
ﬁbrocartilage according to the production of type-I and type-II collagen.
Regarding the real-time PCR analysis, BMP-2, BMP-7, and COL2A1 gene
expression were up regulated by the treatment of simvastatin, sug-
gesting that the up-regulation of those genes might contribute to the
enhanced meniscal healing by simvastatin. In sum, simvastatin could
stimulate meniscus regeneration and healing.
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TRIANGULAR FIBROCARTILAGE COMPLEX INJURY ACCOMPANIED BY
DISTAL RADIUS FRACTURE
E. Yamabe y, Y. Obara z, T. Nakamura z. y Saiseikai Yokohamashi Tobu
Hosp., Yokohama City, Japan; z Sanno Hosp., Tokyo, Japan
Purpose: Recently, open reduction and internal ﬁxation (ORIF) with
volar locking plate is the standard procedure for unstable or intra-
articular distal radius fracture. However, the injury of triangular ﬁbro-
cartilage complex (TFCC), which is associated with the instability of
distal radioulnar joint (DRUJ) and the rotation of forearm, is prone to be
ignored or underestimated at the operation. It might be lead to the
osteoarthritis of radiocarpal joint (RCJ) or DRUJ if the serious injury of
TFCC is untreated. The need and indication for the repair of TFCC at the
initial operation is still unknown and controversial. In the present study,
we analyzed the relationship among the preoperative radiographs of
the wrist, the arthroscopic ﬁndings of TFCC in patients who underwent
ORIF of the radius, and clinical outcome, and assessed the poor prog-
nosis factors after ORIF.
Methods: We examined thirty wrists from thirty patients who under-
went ORIF of the radius (mean age: 59.2; male: 13, female: 17). The
types of fracture according to AO classiﬁcation were as follows; A2: 3,
A3: 8, B1: 1, B2: 1, B3: 2, C1: 10, C2: 2, and C3: 3. Mean follow up period
after the operation was 7.8 months. Before the ﬁxation of fracture, we
observed the TFCC from the RCJ and DRUJ with the wrist arthroscopic
scope, which was 2.7mm in diameter, and ORIF with volar locking plate
was performed. In the present study, we performed the synovectomy
and trimmed the edge of injured TFCC after the ﬁxation, and the repairs
of the disc proper/ligament were not done. Relationships among the
ulnar factor from gadiographic ﬁndings such as the styloid fracture of
ulna or sigmoid notch fracture of radius, arthroscopic ﬁndings of TFCC,
and clinical outcome at the last visit using quick-DASH score (Japanese
version) were assessed.
Results: In 30 patients, the styloid fractures of ulna were found in 16
cases (base of the styloid: 11, middle of the styloid: 1, and tip of the
styloid: 4). Acute tear of TFCCwere found in 12 cases (I-A: 2, I-B: 2, I-D: 8,
respectively, according to Palmer classiﬁcation) and degenerative tear of
TFCC were found in 10 cases (II-A: 4, II-B: 1, II-C: 5, respectively,
according to Palmer classiﬁcation). Though therewere 12 cases that had
moderate symptom/disability with 15 and over points of quick-DASH
score, all of them had the injury of TFCC (I-B: 1, I-D: 4, II-A: 1, II-B: 1, and
II-C: 5, respectively). In 16 caseswith the fracture of styloid of ulna, there
were 8 cases (base of styloid: 6, and tip of the styloid: 2) which had
moderate symptom/disability with 15 and over point of quick-DASH. Alldistal radius fractures with styloid fracture and without TFCC tear
showed good clinical outcomes under 15 points of quick-DASH score.
Conclusions: It is difﬁcult to judge the prognosis from the presence
and/or site of the fracture of the styloid of ulna and arthroscopic eval-
uation of TFCC is essential when the instability of TFCC is anticipated.
Most of degenerative tear of TFCC in elder patients are perforations with
chondromalacia of the lunage and/or ulna (Palmer class II-C) and we
should strictly correct the plus variance of ulna. On the other hand, in
younger patients, radial avulsions of TFCC (Palmer class I-D) were fre-
quently seen. If the dorsal and/or volar radioulnar ligament was dam-
aged, the repair of TFCC at the initial operation is desirable.
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SURGERY, CARTILAGE INJURY AND PATIENT-REPORTED MEASURES
WITHIN 4 WEEKS OF ACL RUPTURE ARE ASSOCIATED WITH 5 YEAR
OUTCOME: EXPLORATORY ANALYSIS OF THE KANON TRIAL
S.R. Filbay y, R.B. Frobell z, S. Lohmander z, E.M. Roos x. yThe Univ. of
Queensland, Brisbane, Australia; ‡Lund Univ., Lund, Sweden; §Univ. of
Southern Denmark, Odense, Denmark
Purpose: Anterior cruciate ligament (ACL) rupture increases the risk of
early-onset knee osteoarthritis, persistent pain, activity restrictions and
poor quality of life (QOL). This study explores data from the KANON
trial, an RCT of 121 ACL ruptured patients randomised to a strategy of
rehabilitation with optional delayed ACL reconstruction (ACLR) or
rehabilitation and early ACLR. Results from the KANON trial are ideal for
investigating long-term outcome following ACL rupture.We explore the
relationship between 5 year patient-reported outcome and (i) con-
comitant joint injury; (ii) surgical intervention; (iii) and baseline
patient-reported measures.
Methods: We explored KANON data from baseline (within 4 weeks of
injury) and 5 years. Between baseline and 5 years, 30 patients assigned to
rehabilitation and optional ACLR underwent a delayed ACLR. One patient
was lost to follow-up between baseline and 5 years (early ACLR), and 2
patients were excluded from analysis due to poor compliance or not
receiving assigned treatment (early ACLR (n¼59), delayed ACLR (n¼30),
no ACLR (n¼29)). Meniscus partial resection or ﬁxationwas performed in
all groups when indicated. Detailed study methodology has been pub-
lished. In contrast to previous publications, this exploratory study will
analyse early ACLR and delayed ACLR as one group (n¼89). Five year
outcomes included the Knee Injury and Osteoarthritis Outcome Score
(KOOS) (pain, symptoms, sport/rec, QOL subscales) and KOOS individual
item Q3 (trouble with knee conﬁdence, none-to-mild vs. moderate-to-
extreme). Baseline concomitant injuries conﬁrmed by MRI included
cartilage injury (yes/no), subchondral fracture (yes/no) and meniscus
injury (yes/no). Treatment related factors included medial meniscus
surgery (yes/no), lateral meniscus surgery (yes/no) and ACLR at baseline
or during the 5 years follow-up (yes/no). Patient-reported measures at
baseline included KOOS4 (an aggregate score fromKOOS pain, symptoms,
sport/rec, and QOL subscales) and the SF-36 (physical component score
(PCS) and mental component score (MCS)). Relationships were explored
usingMann-Whitney U, Kruskal-Wallis ANOVA, Chi2 and Spearman's rho
(r) tests as appropriate. Data was non-normally distributed and reported
values are median (IQR). The KOOS and SF-36 scores range from 0 to 100,
worst to best. No corrections for multiplicity were done.
Results: Participants with baseline cartilage injury (27%) reported
worse KOOS pain (93(79-100)) vs. 97(89-100)), symptoms (77(64-93)
vs. 89(82-100)), sport/rec (78(58-90) vs. 85(70-100)), and QOL (72(39-
81) vs. 75(56-88)) at 5 years compared to patients without cartilage
injury. MRI diagnosed subchondral fracture (31%) and meniscus injury
(53%) were not related to 5 year outcomes. Receiving medial meniscus
surgery between baseline and 5 years (37%) was related to worse KOOS
pain (93(81-97) vs. 97(91-100)), QOL (63(44-81) vs. 78(56-88)) and
knee conﬁdence (moderate-to-extreme trouble, 43% vs. 22%, p¼0.01) at
5 years. Undergoing lateral meniscus surgery (35%) was not related to 5
year outcome. Receiving an ACLR resulted in worse KOOS symptom
scores at follow-up (no ACLR: 96(84-100) vs. ACLR: 86(71-96)) (early
ACLR: 86(75-96), delayed ACLR: 89(71-97)). Patients treated with
rehabilitation alone reported more moderate-to-extreme trouble with
knee conﬁdence (no ACLR: 52% vs. ACLR: (23%) (early ACLR: 22%,
delayed ACLR: 23%) at 5 years. Impaired baseline SF-36 PCS were
associated with worse KOOS pain (r¼.39), symptoms (r¼.26), sport/rec
(r¼.28), QOL (r¼.29), and knee conﬁdence at 5 years. In comparison,
baseline SF-36 MCS was only mildly related to knee pain at 5 years
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A275(r¼.20). Baseline KOOS4 scores were also related to all 5 year KOOS
subscores (all outcomes p<0.01, r¼.23 to r¼.29) (Table 1).
Conclusions: Cartilage injury at baseline was related to worse patient
reported 5 year outcome. Baseline subchondral fracture and meniscus
injury were not related to 5 year outcome, however, receiving medial
meniscus surgerywas related toworse pain,QOL andkneeconﬁdence at 5
year follow-up. In comparison, lateralmeniscus surgerywasnot related to
5 year outcome. Undergoing ACLR (early or delayed) was associated with
more knee symptoms at 5 years and treatment with rehabilitation alone
resulted in worse knee conﬁdence. More joint pain, symptoms, poorer
physical function and worse QOL in the acute phase of ACL injury, were
related to worse 5 year outcome, irrespective of intervention.
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MICRORNA-33A REGULATES CHOLESTEROL SYNTHESIS AND
CHOLESTEROL EFFLUX RELATED GENES IN OSTEOARTHRITIC
CHONDROCYTES
F. Kostopoulou y, K.N. Malizos z, I. Papathanasiou y, A. Tsezou y. yDept. of
Cytogenetics and Molecular Genetics, Univ. of Thessaly, Larissa, Greece;
zDept. of Orthopaedics, Univ. of Thessaly, Larissa, Greece
Purpose: Several studies have shown that osteoarthritis (OA) is strongly
associated to metabolic related disorders, highlighting OA as the ﬁfth
component of the Metabolic Syndrome (MetS). Based on our previous
ﬁndings on dysregulation of cholesterol homeostasis in OA, we were
prompted to investigate whether microRNA-33a (miR-33a), one of the
master regulators of cholesterol and fatty acid metabolism, plays a key
role in osteoarthritis' pathogenesis.
Methods: Articular cartilage samples were obtained from 14 patients
with primary osteoarthritis undergoing total knee replacement surgery.
Normal cartilage was obtained from 9 individuals undergoing fracture
repair surgery with no history of joint disease. Bioinformatics was used
to identify miR-33a target genes. MiR-33a and Sterol Regulatory Ele-
ment Binding Protein 2 (SREBP-2) expression levels were investigated
using real-time PCR and their expression was also assessed after
treatment with Transforming Growth Factor-beta (TGF-beta) in cul-
tured chondrocytes. Investigation of Akt phosphorylation after treat-
ment with both TGF-beta and miR-33a inhibitor was assessed by
western blot analysis. Furthermore, we evaluated the effect of miR-33amimic and miR-33a inhibitor on cholesterol efﬂux related genes, ATP-
binding-cassette transporter A1 (ABCA1), Apolipoprotein A1 (ApoA1),
liver X receptors (LXRalpha and LXRbeta), as well as on matrix metal-
loproteinase-13 (MMP-13) using real time PCR assay.
Results: We found that the expression of miR-33a and its host gene
SREBP-2 were signiﬁcantly elevated in OA chondrocytes compared to
normal. We also showed that treatment of cultured chondrocytes with
TGF-beta resulted in increased expression of both miR-33a and SREBP-
2, while the TGF-beta-induced Akt phosphorylation was suppressed by
inhibition of miR-33a. Moreover, we demonstrated that treatment of
normal chondrocytes with miR-33a resulted in ABCA1 and ApoA1 sig-
niﬁcantly reduced mRNA expression levels and signiﬁcantly elevated
MMP-13 expression levels, promoting the OA phenotype, while miR-
33a's suppressive effect was reversed using its inhibitor.
Conclusions: Our ﬁndings suggest, for the ﬁrst time to our knowledge,
that miR-33a regulates cholesterol synthesis through the TGF-beta/Akt/
SREBP-2 pathway, and cholesterol efﬂux related genes ABCA1 and
ApoA1 in OA chondrocytes, pointing to its identiﬁcation as a novel
target for ameliorating the OA phenotype.
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THE ROLE OF MICRORNA-140 IN OSTEOARTHRITIS
T. Karlsen y,z, G. de Souza z, J. Brinchmann y,z. yNorwegian Center for
Stem Cell Research, Oslo, Norway; zDept. of Immunology, Oslo Univ.
Hosp., Oslo, Norway
Purpose: The purpose of this study was to determine the role of
microRNA-140 in an in vitro model of osteoarthritis (OA).
Methods: Human articular chondrocytes (ACs) and synovial ﬁbroblasts
(SFs) were isolated from patients undergoing total knee replacement
and anterior cruciate ligament surgery, respectively. Addition of
recombinant IL1B to cell cultures was used as an in vitro model of OA.
All patients provided written, informed consent. Electroporation was
used to overexpress microRNA-140. Real-time PCR was used to quantify
mRNA levels and genome-scale proteome quantiﬁcationwas performed
using mass spectrometry. ELISA and western blotting were used to
validate results from the proteome analysis.
Results: IL1B-stimulation of ACs resulted in upregulation and down-
regulation of 200 and 160 proteins, respectively. The upregulated pro-
teins included several pro-inﬂammatorymolecules such as IL1B, IL6, IL8
and the matrix degradation molecules MMP3 and MMP13. All these
proteins are known to be involved in the pathogenesis of OA.
When microRNA-140 was overexpressed in IL1B-stimulated ACs 100
and 90 proteins were downregulated and upregulated, respectively. The
downregulated proteins included IL1B, IL6, IL8, proteins involved in NF-
kappaB signaling and other proteins that are associated with OA.
However, MMP3 and MMP13 were not affected. ACAN, CSGALNACT1
(involved in chondroitin sulfate biosynthesis), proteins involved in
hyaluronan synthesis/binding and inhibitors of NF-kappaB signaling
were among the proteins that were upregulated by miR-140. The
remaining proteins were mainly associated with cell cycle and
metabolism.
Conclusions: Addition of low levels of IL1B to cultures of ACs or SFs
constitute useful in vitro models for the pathogenesis of OA. In this
study we show that microRNA-140 protects against OA by inhibiting
key inﬂammatory molecules and stimulating synthesis of important
cartilage molecules. Delivery of microRNA-140 into OA joints may
represent a viable treatment strategy.
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MICRORNA-455 TARGETS SIRT1
T.E. Swingler y, Y. Wormstone y, M. Lott y, M. Barter z, D. Young z,
I.M. Clark y. yUniv. of East Anglia, Norwich, United Kingdom; zUniv. of
Newcastle, Newcastle, United Kingdom
Purpose: MicroRNAs (miRNAs) have emerged as a new class of gene
expression regulators that are important in both normal cartilage
physiology and pathology. MicroRNAs are 20-24 nucleotide non-
coding RNA molecules that post-transcriptionally regulate gene
expression. A single miRNA can regulate multiple mRNAs via binding
to sequences in the 30UTR either promoting mRNA decay or repres-
sing translation. We have previously identiﬁed several microRNAs
that are regulated during chondrogenesis and in osteoarthritic car-
tilage, including microRNA-455, a key Sox9-responsive microRNA.
